A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems

Not Applicable

Completed

• Conditions: Candidiasis, Esophageal; HIV Infections

• Registration Number: NCT00002304
• Lead Sponsor: Pfizer

Brief Summary

To compare the safety, tolerance, and effectiveness of fluconazole and ketoconazole in the treatment of candidal esophagitis in immunocompromised patients.

Detailed Description

Not available

Study Timeline

• Status Verified: 1990-02
• Study First Submitted: 1999-11-02
• Study First Submitted QC: 2001-08-30
• Study First Posted: 2001-08-31
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (42)

Good Samaritan Med Ctr; 🇺🇸 Phoenix, Arizona, United States

Arkansas Children's Hosp; 🇺🇸 Little Rock, Arkansas, United States

Los Angeles County - USC Med Ctr; 🇺🇸 Los Angeles, California, United States

Eisenhower Med Ctr; 🇺🇸 Rancho Mirage, California, United States

ViRx Inc; 🇺🇸 San Francisco, California, United States

UCSF Hosp; 🇺🇸 San Francisco, California, United States

George Washington Univ Med Ctr; 🇺🇸 Washington, District of Columbia, United States

Regional Oncology Ctr; 🇺🇸 Daytona Beach, Florida, United States

Ctr for Special Immunology; 🇺🇸 Fort Lauderdale, Florida, United States

Mem Hosp Hollywood; 🇺🇸 Hollywood, Florida, United States

Scroll for more (32 remaining)